Myriad Genetics (NASDAQ: MYGN) revenue
Myriad Genetics reported revenue of $824.5m for fiscal 2025, 1.6% less than in fiscal 2024 ($837.6m). Since fiscal 2016 its revenue has grown by 11.3%, an average growth of 1.1% a year.
Myriad Genetics's best year of the last 10 was fiscal 2019. The biggest drop was in fiscal 2022, −1.8%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $824.5m | −1.6% | −$387.2m | −47.0% |
| 2024 | $837.6m | +11.2% | −$123.5m | −14.7% |
| 2023 | $753.2m | +11.0% | −$257.4m | −34.2% |
| 2022 | $678.4m | −1.8% | −$140.6m | −20.7% |
| 2021 | $690.6m | +24.0% | −$190.5m | −27.6% |
| 2020 | $557.1m | — | −$289.7m | −52.0% |
| 2019 | $851.1m | +14.4% | $7.6m | 0.9% |
| 2018 | $743.7m | +2.1% | $121.9m | 16.4% |
| 2017 | $728.7m | −1.6% | $44.0m | 6.0% |
| 2016 | $740.5m | — | $153.4m | 20.7% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Myriad Genetics revenue compared with its sector
By revenue for its latest fiscal year, Myriad Genetics ranks 165th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Myriad Genetics, −1.6%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 163rd | Varex Imaging | $844.6m | 4.1% |
| 164th | Arrowhead Pharmaceuticals | $829.4m | 23,258.2% |
| 165th | Myriad Genetics | $824.5m | −1.6% |
| 166th | Orthofix Medical | $822.3m | 2.9% |
| 167th | GoodRx | $796.9m | 0.6% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Myriad Genetics
- How much revenue did Myriad Genetics make in fiscal 2025?
- Myriad Genetics reported revenue of $824.5m for fiscal 2025, compared with $837.6m in fiscal 2024.
- How much has the revenue of Myriad Genetics grown?
- Between fiscal 2016 and fiscal 2025 it went from $740.5m to $824.5m: 11.3% more, an average growth of 1.1% a year.
- What was the best year for revenue at Myriad Genetics?
- Of its last 10 fiscal years, fiscal 2019, with $851.1m.
- Where does Myriad Genetics rank in its sector by revenue?
- It ranks 165th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Myriad Genetics come from?
- From the annual report (Form 10-K) that Myriad Genetics files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Myriad Genetics files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Myriad Genetics: the Myriad Genetics page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.